VNDA
Vanda Pharmaceuticals Inc
5.20$
+1.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -162.6% | 11.3% | -5.5% | -1.2% | 15.5% | 20.2% | 20.9% | 23.9% | 12.6% | 6.6% | -7.9% | -50.6% | |
| 5.6% | 12.3% | 8.1% | 1.8% | 1.5% | 1.3% | 1.2% | 1.1% | 1.1% | 1.6% | 4.1% | -0.4% | |
| 11.7% | 7.2% | 5.9% | 6.3% | 6.0% | 5.9% | 5.4% | 5.7% | 6.4% | 7.3% | 6.3% | 4.4% | |
| -143.0% | 7.8% | 6.2% | 6.7% | 6.1% | -31.9% | 8.6% | 8.9% | 7.8% | – | – | – | |
| -65.7% | 26.8% | -7.6% | 0.0% | -4.0% | 1.4% | 1.7% | 1.0% | 2.4% | -0.4% | -3.3% | 3.8% | |
| 17.5% | 2.3% | 1.0% | 1.0% | 13.1% | 0.4% | 0.7% | 0.2% | 0.3% | 0.2% | 0.2% | 0.5% | |
| -24.0% | -24.2% | -6.9% | -6.1% | -56.8% | -30.1% | -16.7% | -28.5% | 19.6% | -6.3% | -8.8% | 43.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 129.9% | -0.3% | 5.3% | 3.2% | 55.5% | 2.8% | 2.3% | 1.3% | 0.3% | – | – | – | |
| – | – | – | – | – | – | – | – | 0.0% | 0.0% | -0.1% | -0.9% | |
| 178.9% | 3.7% | 5.3% | 3.2% | 55.5% | 2.8% | 2.3% | 1.3% | 0.3% | 0.3% | -0.1% | -1.3% | |
| -7.7% | -9.1% | -7.1% | -4.1% | 14.2% | -7.1% | 6.5% | -3.4% | 32.6% | 0.4% | -16.9% | -8.0% | |
| -180.1% | 9.0% | -6.5% | -2.2% | 2.4% | 19.8% | 20.1% | 23.7% | 12.3% | 6.4% | -8.2% | -51.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.